| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lin,Zhi-Hui | Chairman | 38.97% | SYNMOSA BIOPHARMA CORPORATION |
| Qiu,Hui-Lan | Director | 38.97% | SYNMOSA BIOPHARMA CORPORATION |
| Huang,Qi-Ying | Director | 5.35% | NATIONAL DEVELOPMENT FUND MANAGEMENT COMMITTEE, EXECUTIVE YUAN |
| Zhou,De-Qian | Director | 0.31% | LIAN JIE INVESTMENT CO., LTD. |
| ZHONG JIA INVESTMENT DEVELOPMENT CO., LTD. | Director | 0.12% | |
| Xue,Yu-Mei | Director | 0.01% | |
| Fan,De-Quan | Independent Director | 0.00% | |
| Lin,Xiu-Mei | Independent Director | 0.08% | |
| Chen,Fang-Ping | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 7,656 | 39,779 | 25,847 |
| Operating cost | 48,165 | 197,404 | 189,842 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | -40,509 | -157,625 | -163,995 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | -40,509 | -157,625 | -163,995 |
| Operating expenses | 42,440 | 198,502 | 156,473 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -82,949 | -356,127 | -320,468 |
| Non-operating income and expenses | -5,403 | -12,080 | -17,519 |
| Net profit (loss) before tax | -88,352 | -368,207 | -337,987 |
| Income tax expense (benefits) | - | - | - |
| Net profit (loss) of ongoing business for the current period | -88,352 | -368,207 | -337,987 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -88,352 | -368,207 | -337,987 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -88,352 | -368,207 | -337,987 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | -2 | -2 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -98,353 | - | - |
| Net cash inflows (outflows) from investing activities | 34,805 | - | - |
| Net cash inflow (outflow) from financing activities | 72,080 | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 6 | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | 8,538 | - | - |
| Beginning balance of cash and cash equivalents | 198,653 | - | - |
| Ending balance of cash and cash equivalents | 207,191 | - | - |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 397,747 | 410,324 | 695,021 |
| Non-current asset | 1,974,726 | 1,985,478 | 2,016,047 |
| Total asset | 2,372,473 | 2,395,802 | 2,711,068 |
| Current liability | 446,113 | 386,644 | 568,726 |
| Non-current liability | 1,198,229 | 1,194,879 | 974,494 |
| Total liability | 1,644,342 | 1,581,523 | 1,543,220 |
| share capital | 1,379,240 | 1,379,440 | 1,374,085 |
| Equity - secruity token | - | - | - |
| capital reserve | 19,405 | 19,762 | 286,160 |
| retained earning | -668,111 | -579,759 | -488,082 |
| Other equity | -2,403 | -5,164 | -4,315 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 728,131 | 814,279 | 1,167,848 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 5 | 5 | 8 |
